However, high levels of both AKT1 and HSPB1 or both EGFR and HSPB1 provided more prognostic information on survival (Fig. 1E), suggesting that HSP27 in combination with AKT or EGFR serves as a strong risk factor for survival in NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.